T Therapeutics
Home - T-Therapeutics
Cambridge, United Kingdom · Founded 2022 · $60.0M raised
- Headquarters
- Cambridge
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- t-therapeutics.com
- Total Funding
- $60.0M
- Last Round
- $60.0M Series ANov 2023
- Rounds
- 1
About
T-Therapeutics is a next-generation T cell receptor (TCR) company spun out from the University of Cambridge, developing treatments for cancer and autoimmune disease. The company uses its proprietary OpTiMus platform — based on a fully humanized TCR mouse — combined with single-cell genomics, machine learning, and structural biology to generate antigen-specific human TCRs targeting previously undruggable classes.
Summary
T Therapeutics is a Biotech company based in Cambridge, United Kingdom, founded in 2022. It has raised $60.0M in total across 1 round, most recently a $60.0M Series A round in Nov 2023.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2023
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...